Detection rate of actionable mutations in diverse cancers using a biopsy-free (blood) circulating tumor cell DNA assay

// Maria Schwaederle 1 , Hatim Husain 1 , Paul T. Fanta 1 , David E. Piccioni 1 , Santosh Kesari 1 , Richard B. Schwab 1 , Kimberly C. Banks 2 , Richard B. Lanman 2 , AmirAli Talasaz 2 , Barbara A. Parker 1 , Razelle Kurzrock 1 1 Center for Personalized Cancer Therapy and Division of Hematology and Oncology, UCSD Moores Cancer Center, La Jolla, CA, USA 2 Guardant Health, Inc., Redwood City, CA, USA Correspondence to: Maria Schwaederle, e-mail:...